PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Antibodies Against Lysophosphatidic Acid Protect Against Blast-Induced Ocular Injuries.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33384658 ↗2020Reported benefit

Antibodies Against Lysophosphatidic Acid Protect Against Blast-Induced Ocular Injuries.

RatTBIBlast / overpressureSprague DawleyMalen = 6 animals per group for all outcome measures; overall total…Intravenous25 mg/kgOne hour after blast exposure

Model: Single primary blast overpressure exposure in an Advanced Blast Simulator, peak positive static pressure approximately 19 psi with a positive phase duration of 4 to 5 ms, animals prone and facing the shockwave

Blast raised several plasma LPA species at 1 and 4 hours, and a single 25 mg/kg intravenous dose of anti-LPA antibody at 1 hour preserved visual acuity at days 2 and 6, prevented the fall in electroretinogram amplitudes, reduced retinal degeneration and blocked Muller cell activation, although acui…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.